Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 858027, 13 pages
http://dx.doi.org/10.1155/2015/858027
Review Article

The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review

Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria

Received 18 September 2014; Revised 26 January 2015; Accepted 3 February 2015

Academic Editor: Aurelia Rughetti

Copyright © 2015 Andreas Kronbichler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. H. Beck Jr., R. G. B. Bonegio, G. Lambeau et al., “M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy,” The New England Journal of Medicine, vol. 361, no. 1, pp. 11–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. N. M. Tomas, L. H. Beck Jr., C. Meyer-Schwesinger et al., “Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy,” The New England Journal of Medicine, vol. 371, no. 24, pp. 2277–2287, 2014. View at Publisher · View at Google Scholar
  3. W. G. Couser and R. J. Johnson, “The etiology of glomerulonephritis: roles of infection and autoimmunity,” Kidney International, vol. 86, no. 5, pp. 905–914, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Pieterse and J. van der Vlag, “Breaking immunological tolerance in systemic lupus erythematosus,” Frontiers in Immunology, vol. 5, article 164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Elson, I. Dunn-Siegrist, B. Daubeuf, and J. Pugin, “Contribution of toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria,” Blood, vol. 109, no. 4, pp. 1574–1583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. J. Turnbaugh, R. E. Ley, M. Hamady, C. M. Fraser-Liggett, R. Knight, and J. I. Gordon, “The human microbiome project,” Nature, vol. 449, no. 7164, pp. 804–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Valentini, A. Piermattei, G. di Sante, G. Migliara, G. Delogu, and F. Ria, “Immunomodulation by gut microbiota: role of Toll-like receptor expressed by T cells,” Journal of Immunology Research, vol. 2014, Article ID 586939, 8 pages, 2014. View at Publisher · View at Google Scholar
  8. I. Cho and M. J. Blaser, “The human microbiome: at the interface of health and disease,” Nature Reviews Genetics, vol. 13, no. 4, pp. 260–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. M. Kosiewicz, A. L. Zirnheld, and P. Alard, “Gut microbiota, immunity, and disease: a complex relationship,” Frontiers in Microbiology, vol. 2, article 180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. H. Nasr, J. Radhakrishnan, and V. D. D'Agati, “Bacterial infection-related glomerulonephritis in adults,” Kidney International, vol. 83, no. 5, pp. 792–803, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Millet, M. Pederzoli-Ribeil, L. Guillevin, V. Witko-Sarsat, and L. Mouthon, “Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?” Annals of the Rheumatic Diseases, vol. 72, no. 8, pp. 1273–1279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Stegeman, J. W. Cohen Tervaert, W. J. Sluiter, W. L. Manson, P. E. de Jong, and C. G. M. Kallenberg, “Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis,” Annals of Internal Medicine, vol. 120, no. 1, pp. 12–17, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. C. A. Stegeman, J. W. C. Tervaert, P. E. de Jong, and C. G. M. Kallenberg, “Trimethoprim-sulfamethoxazole (Co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis,” The New England Journal of Medicine, vol. 335, no. 1, pp. 16–20, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Zycinska, K. A. Wardyn, T. M. Zielonka, U. Demkow, and M. S. Traburzynski, “Chronic crusting, nasal carriage of Staphylococcus aureus and relapse rate in pulmonary wegener's granulomatosis,” Journal of Physiology and Pharmacology, vol. 59, supplement 6, pp. 825–831, 2008. View at Google Scholar · View at Scopus
  15. E. R. Popa, C. A. Stegeman, W. H. Abdulahad et al., “Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis,” Rheumatology, vol. 46, no. 6, pp. 1029–1033, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. E. R. Popa, C. A. Stegeman, N. A. Bos, C. G. M. Kallenberg, and J. W. C. Tervaert, “Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis,” Clinical & Experimental Immunology, vol. 132, no. 3, pp. 496–504, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. H. Brons, H. I. Bakker, R. T. Van Wijk et al., “Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?” Clinical and Experimental Immunology, vol. 119, no. 3, pp. 566–573, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Savige, L. Nassis, T. Cooper, B. Paspaliris, P. Martinello, and D. MacGrego, “Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins,” Clinical and Experimental Rheumatology, vol. 20, no. 6, pp. 783–789, 2002. View at Google Scholar · View at Scopus
  19. R. Kain, K. Matsui, M. Exner et al., “A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells,” Journal of Experimental Medicine, vol. 181, no. 2, pp. 585–597, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Kain, M. Exner, R. Brandes et al., “Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis,” Nature Medicine, vol. 14, no. 10, pp. 1088–1096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. Roth, M. C. Brown, R. N. Smith et al., “Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis,” Journal of the American Society of Nephrology, vol. 23, no. 3, pp. 545–555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Huugen, H. Xiao, A. Van Esch et al., “Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-α,” American Journal of Pathology, vol. 167, no. 1, pp. 47–58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Peschel, N. Basu, A. Benharkou et al., “Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN,” Journal of the American Society of Nephrology, vol. 25, no. 3, pp. 455–463, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Jennette, R. J. Falk, P. A. Bacon et al., “2012 revised international Chapel Hill Consensus Conference nomenclature of vasculitides,” Arthritis & Rheumatism, vol. 65, no. 1, pp. 1–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. Davin, “Henoch-Schönlein purpura nephritis: pathophysiology, treatment, and future strategy,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 3, pp. 679–689, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. C. N. Inoue, S. Matsutani, M. Ishidoya, R. Homma, Y. Chiba, and T. Nagasaka, “Periodontal and ENT therapy in the treatment of pediatric henoch-schönlein purpura and IgA nephropathy,” Advances in Oto-Rhino-Laryngology, vol. 72, pp. 53–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Masuda, K. Nakanishi, N. Yoshizawa, K. Iijima, and N. Yoshikawa, “Group A streptococcal antigen in the glomeruli of children with Henoch-Schönlein nephritis,” The American Journal of Kidney Diseases, vol. 41, no. 2, pp. 366–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Al-Sheyyab, A. Batieha, H. El-Shanti, and A. Daoud, “Henoch-Schonlein purpura and streptococcal infection: a prospective case-control study,” Annals of Tropical Paediatrics, vol. 19, no. 3, pp. 253–255, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Schmitt, F. Carlsson, M. Mörgelin, R. Tati, G. Lindahl, and D. Karpman, “Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch-Schönlein purpura,” The American Journal of Pathology, vol. 176, no. 2, pp. 608–618, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Hirayama, M. Kobayashi, K. Muro, K. Yoh, K. Yamagata, and A. Koyama, “Specific T-cell receptor usage with cytokinemia in Henoch-Schönlein purpura nephritis associated with Staphylococcus aureus infection,” Journal of Internal Medicine, vol. 249, no. 4, pp. 289–295, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. Q. Li, X. Lin, Z. Wu et al., “Immuno-histochemistry analysis of Helicobacter pylori antigen in renal biopsy specimens from patients with glomerulonephritis,” Saudi Journal of Kidney Disease and Transplantation, vol. 24, no. 4, pp. 751–758, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Ogura, S. Suzuki, T. Shirakawa et al., “Haemophilus parainfluenzae antigen and antibody in children with IgA nephropathy and Henoch-Schönlein nephritis,” American Journal of Kidney Diseases, vol. 36, no. 1, pp. 47–52, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Kanai, E. Sawanobori, A. Kobayashi, K. Matsushita, K. Sugita, and K. Higashida, “Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy proteinuric henoch-schönlein purpura nephritis in children,” Nephron Extra, vol. 1, no. 1, pp. 101–111, 2011. View at Publisher · View at Google Scholar
  34. R. J. Wyatt and B. A. Julian, “MEdical progress: IgA nephropathy,” The New England Journal of Medicine, vol. 368, no. 25, pp. 2402–2414, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Huang, W. Sun, Y. Liang et al., “Comparative study of bacterial strains and antibiotic susceptibility tests between chronic tonsillitis patients with IgA nephropathy and without nephritis,” Renal Failure, vol. 35, no. 10, pp. 1334–1337, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Nagasawa, K. Iio, S. Fukuda et al., “Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment,” PLoS ONE, vol. 9, no. 1, Article ID e81636, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Kusano, O. Tokunaga, T. Ando, and A. Inokuchi, “Helicobacter pylori in the palatine tonsils of patients with IgA nephropathy compared with those of patients with recurrent pharyngotonsillitis,” Human Pathology, vol. 38, no. 12, pp. 1788–1797, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Kusano, A. Inokuchi, K. Fujimoto et al., “Coccoid Helicobacter pylori exists in the palatine tonsils of patients with IgA nephropathy,” Journal of Gastroenterology, vol. 45, no. 4, pp. 406–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Schmitt, G. Lindahl, and D. Karpman, “Antibody response to IgA-binding streptococcal M proteins in children with IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 25, no. 10, pp. 3434–3436, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Suzuki, Y. Nakatomi, S. Odani, H. Sato, F. Gejyo, and M. Arakawa, “Circulating IgA, IgG, and IgM class antibody against Haemophilus parainfluenzae antigens in patients with IgA nephropathy,” Clinical and Experimental Immunology, vol. 104, no. 2, pp. 306–311, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. P. A. Drew, W. N. Nieuwhof, A. R. Clarkson, and A. J. Woodroffe, “Increased concentration of serum IgA antibody to pneumococcal polysaccharides in patients with IgA nephropathy,” Clinical & Experimental Immunology, vol. 67, no. 1, pp. 124–129, 1987. View at Google Scholar · View at Scopus
  42. J. Barratt, E. M. Bailey, K. S. Buck et al., “Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy,” The American Journal of Kidney Diseases, vol. 33, no. 6, pp. 1049–1057, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Suzuki, F. Gejyo, Y. Nakatomi, S. Odani, H. Sato, and M. Arakawa, “Role of IgA, IgG, and IgM antibodies against haemophilus parainfluenzae antigens in IgA nephropathy,” Clinical Nephrology, vol. 46, no. 5, pp. 287–295, 1996. View at Google Scholar · View at Scopus
  44. Y. Ogawa, A. Ishizu, H. Ishikura, and T. Yoshiki, “Elution of IgA from kidney tissues exhibiting glomerular IgA deposition and analysis of antibody specificity,” Pathobiology, vol. 70, no. 2, pp. 98–102, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Hirabayashi, N. Yorioka, H. Oda et al., “Involvement of bacterial antigens in immunoglobulin A nephropathy,” Hiroshima Journal of Medical Sciences, vol. 45, no. 4, pp. 113–117, 1996. View at Google Scholar · View at Scopus
  46. Y. Shimizu, M. Seki, S. Kaneko et al., “Patients with IgA nephropathy respond strongly through production of IgA with low avidity against Staphylococcus aureus,” Contributions to Nephrology, vol. 157, pp. 139–143, 2007. View at Google Scholar · View at Scopus
  47. A. Koyama, S. Sharmin, H. Sakurai et al., “Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy,” Kidney International, vol. 66, no. 1, pp. 121–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Nishikawa, R. Shibata, Y. Ozono et al., “Streptococcal M protein enhances TGF-β production and increases surface IgA-positive B cells in vitro in IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 15, no. 6, pp. 772–777, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Liu, Y. Peng, F. Liu, W. Xiao, Y. Zhang, and W. Li, “Expression of IgA class switching gene in tonsillar mononuclear cells in patients with IgA nephropathy,” Inflammation Research, vol. 60, no. 9, pp. 869–878, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Yang, F. G. Li, X. S. Xie, S. Q. Wang, and J. M. Fan, “CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells,” Biochemical and Biophysical Research Communications, vol. 444, no. 2, pp. 276–281, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Suzuki, S. Fujieda, H. Sunaga et al., “Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy,” Clinical and Experimental Immunology, vol. 119, no. 2, pp. 328–332, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Suzuki, S. Fujieda, H. Sunaga, C. Yamamoto, H. Kimura, and F. Gejyo, “Synthesis of immunoglobulins against Haemophilus parainfluenzae by tonsillar lymphocytes from patients with IgA nephropathy,” Nephrology Dialysis Transplantation, vol. 15, no. 5, pp. 619–624, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Fujieda, S. Suzuki, H. Sunaga et al., “Induction of IgA against Haemophilus parainfluenzae antigens in tonsillar mononuclear cells from patients with IgA nephropathy,” Clinical Immunology, vol. 95, no. 3, pp. 235–243, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Sunaga, M. Oh, N. Takahashi, and S. Fujieda, “Infection of Haemophilus parainfluenzae in tonsils is associated with IgA nephropathy,” Acta Oto-Laryngologica, vol. 124, no. 555, pp. 15–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Nozawa, M. Takahara, T. Yoshizaki, T. Goto, N. Bandoh, and Y. Harabuchi, “Selective expansion of T cell receptor (TCR) V beta 6 in tonsillar and peripheral blood T cells and its induction by in vitro stimulation with Haemophilus parainfluenzae in patients with IgA nephropathy,” Clinical and Experimental Immunology, vol. 151, no. 1, pp. 25–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. T.-K. Chao, A. Rifai, S.-M. Ka et al., “The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy,” Kidney International, vol. 70, no. 2, pp. 283–297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Yamamoto, S. Suzuki, H. Kimura, H. Yoshida, and F. Gejyo, “Experimental nephropathy induced by Haemophilus parainfluenzae antigens,” Nephron, vol. 90, no. 3, pp. 320–327, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Sharmin, Y. Shimizu, M. Hagiwara, K. Hirayama, and A. Koyama, “Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice,” Journal of Nephrology, vol. 17, no. 4, pp. 504–511, 2004. View at Google Scholar · View at Scopus
  59. L. Zhang, F. Ye, Y. He et al., “Establishment of a mouse IgA nephropathy model with the MBP-20-peptide fusion protein,” The Anatomical Record, vol. 293, no. 10, pp. 1729–1737, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Kawamura, M. Yoshimura, Y. Miyazaki et al., “A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy,” Nephrology Dialysis Transplantation, vol. 29, no. 8, pp. 1546–1553, 2014. View at Publisher · View at Google Scholar
  61. K. Kiryluk, Y. Li, F. Scolari et al., “Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens,” Nature Genetics, vol. 46, no. 11, pp. 1187–1196, 2014. View at Publisher · View at Google Scholar
  62. H. K. Smerud, P. Bárány, K. Lindström et al., “New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria,” Nephrology Dialysis Transplantation, vol. 26, no. 10, pp. 3237–3242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. M. De Angelis, E. Montemurno, M. Piccolo et al., “Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN),” PLoS ONE, vol. 9, no. 6, Article ID e99006, 2014. View at Publisher · View at Google Scholar
  64. E. Hoxha, I. Thiele, G. Zahner, U. Panzer, S. Harendza, and R. A. K. Stahl, “Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy,” Journal of the American Society of Nephrology, vol. 25, no. 6, pp. 1357–1366, 2014. View at Publisher · View at Google Scholar
  65. M. Waldman and H. A. Austin III, “Treatment of idiopathic membranous nephropathy,” Journal of the American Society of Nephrology, vol. 23, no. 10, pp. 1617–1630, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. V. D. D'Agati, F. J. Kaskel, and R. J. Falk, “Focal segmental glomerulosclerosis,” New England Journal of Medicine, vol. 365, no. 25, pp. 2398–2411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Waldman, R. J. Crew, A. Valeri et al., “Adult minimal-change disease: clinical characteristics, treatment, and outcomes,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 3, pp. 445–453, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Moriyama, T. Kaneko, M. Fujii, Y. Tsubakihara, S. Kawano, and E. Imai, “High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy,” Alimentary Pharmacology and Therapeutics Symposium Series, vol. 2, no. 1, pp. 189–193, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Nagashima, K. Maeda, F. Yuda, K. Kudo, M. Saitoh, and T. Takahashi, “Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy,” Virchows Archiv, vol. 431, no. 4, pp. 235–239, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Gulati, V. Kher, P. Arora, S. Gupta, and S. Kale, “Urinary tract infection in nephrotic syndrome,” The Pediatric Infectious Disease Journal, vol. 15, no. 3, pp. 237–240, 1996. View at Publisher · View at Google Scholar · View at Scopus
  71. O. T. Adedoyin, I. A. Ojuawo, M. S. Odimayo, and E. A. Anigilaje, “Urinary tract infections in children with primary nephrotic syndrome and acute glomerulonephritis,” West African Journal of Medicine, vol. 29, no. 4, pp. 235–238, 2010. View at Google Scholar · View at Scopus
  72. J. Reiser, G. von Gersdorff, M. Loos et al., “Induction of B7-1 in podocytes is associated with nephrotic syndrome,” The Journal of Clinical Investigation, vol. 113, no. 10, pp. 1390–1397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. C.-C. Yu, A. Fornoni, A. Weins et al., “Abatacept in B7-1-positive proteinuric kidney disease,” The New England Journal of Medicine, vol. 369, no. 25, pp. 2416–2423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Kronbichler and G. Mayer, “Renal involvement in autoimmune connective tissue diseases,” BMC Medicine, vol. 11, no. 1, article 95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Kowal, A. Weinstein, and B. Diamond, “Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus,” European Journal of Immunology, vol. 29, no. 6, pp. 1901–1911, 1999. View at Google Scholar
  76. I. A. Chowdhry, C. Kowal, J. Hardin, Z. Zhou, and B. Diamond, “Autoantibodies that bind glomeruli: cross-reactivity with bacterial antigen,” Arthritis & Rheumatism, vol. 52, no. 8, pp. 2403–2410, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. H.-J. Anders, V. Vielhauer, V. Eis et al., “Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice,” The FASEB Journal, vol. 18, no. 3, pp. 534–536, 2004. View at Google Scholar · View at Scopus
  78. G. M. Deng and G. C. Tsokos, “Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation,” Journal of Immunology, vol. 181, no. 6, pp. 4019–4026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. G. S. Gilkeson, J. P. Grudier, D. G. Karounos, and D. S. Pisetsky, “Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA,” Journal of Immunology, vol. 142, no. 5, pp. 1482–1486, 1989. View at Google Scholar · View at Scopus
  80. S. Izui, P. H. Lambert, G. J. Fournié, H. Türler, and P. A. Miescher, “Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identification of circulating DNA and renal localization of DNA-anti-DNA complexes,” The Journal of Experimental Medicine, vol. 145, no. 5, pp. 1115–1130, 1977. View at Publisher · View at Google Scholar · View at Scopus
  81. G. J. Fournié, P. H. Lambert, and P. A. Miescher, “Release of DNA in circulating blood and induction of anti DNA antibodies after injection of bacterial lipopolysaccharides,” The Journal of Experimental Medicine, vol. 140, no. 5, pp. 1189–1206, 1974. View at Publisher · View at Google Scholar · View at Scopus
  82. N. A. Granholm and T. Cavallo, “Bacterial lipopolysaccharides enhances deposition of immune complexes and exacerbates nephritis in BXSB lupus-prone mice,” Clinical and Experimental Immunology, vol. 85, no. 2, pp. 270–277, 1991. View at Google Scholar · View at Scopus
  83. N. A. Granholm and T. Cavallo, “Long-lasting effects of bacterial lipopolysaccharide promote progression of lupus nephritis in NZB/W mice,” Lupus, vol. 3, no. 6, pp. 507–514, 1994. View at Publisher · View at Google Scholar · View at Scopus
  84. T. Cavallo and N. A. Granholm, “Bacterial lipopolysaccharide transforms mesangial into proliferative lupus nephritis without interfering with processing of pathogenic immune complexes in NZB/W mice,” The American Journal of Pathology, vol. 137, no. 4, pp. 971–978, 1990. View at Google Scholar · View at Scopus